Maintenance Olaparib Plus Bevacizumab (Bev) After Platinum-Based Chemotherapy Plus Bev In Patients (Pts) With Newly Diagnosed Advanced High-Grade Ovarian Cancer (Hgoc): Efficacy By Brca1 Or Brca2 Mutation In The Phase Iii Paola-1 Trial.Domenica Lorusso,Jean-Pierre Lotz,Philipp Harter,Claire Cropet, Maria Jesus Rubio Pérez,Christian Schauer,Takashi Matsumoto,Ignace Vergote,Nicoletta Colombo,Trine Jakobi Noettrup,Hugues Pierre Bourgeois,Andreas Schnelzer,Sandro Pignata,Yolanda Garcia,Magali Provansal,Lars Christian Hanker,Dominique Berton,Dirk Bauerschlag,Florence Joly, Isabelle Laure Ray-CoquardJOURNAL OF CLINICAL ONCOLOGY（2020）引用 5|浏览44暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
